Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Lymphomes hodgkinien (maladie de Hodgkin)
- Lymphomes non hodgkinien
- | Specialty :
- Thérapies Ciblées
Extract
A phase IA/II, multi-center, open-label study of HCD122 administered intravenously once weekly for four weeks in adult patients with advanced non-hodgkin's or hodgkin's lymphoma who have progressed after at least two prior therapies.
Scientific Abstract
en cours d'intégration;